CLIN BENEFIT OF MIDODRINE HCL IN PATIENTS W/ NEUROGENIC ORTHOSTATIC H

盐酸米多君对神经源性直立性 H 患者的临床益处

• 批准号: 6265062
• 负责人: DANIEL BLOOMFIELD
• 金额: $ 0.04万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6265062
• 关键词: clinical research; drug screening /evaluation; ethanolamines; human subject; human therapy evaluation; postural hypotension; quality of life

This multicenter, randomized,double-blind study hopes to define the clinical benefit of midodrine in patients with neurogenic orthostatic hypotension. The primary hypothesis is that midodrine improve qualitiy of life by enabling patients to pursue activities of daily living.

这项多中心、随机、双盲研究希望确定米多君在神经源性直立性低血压患者中的临床获益。 主要假设是米多君通过使患者能够进行日常生活活动来改善生活质量。